Coface Reports 9M Revenue of EUR 1.41 Billion
Coface reported a 9M combined ratio of 72.4.
Related stories
Coloplast Expects 5–7% Organic Growth in FY 2026/27
M impact | EARNINGS | Nov 02, 2026, 05:40 PM UTC
Coloplast Sets 2030 Organic Revenue Growth and EBIT Margin Targets
Coloplast targets annual organic revenue growth of 5–7% and an EBIT margin in the mid-20% range through 2030.
M impact | EARNINGS | Nov 02, 2026, 05:39 PM UTC
Coloplast Expects FY 2026/27 EBIT Margin Around 25%
M impact | EARNINGS | Nov 02, 2026, 05:39 PM UTC
Coloplast Q4 Adjusted EBIT DKK 1,848 Million
M impact | EARNINGS | Nov 02, 2026, 05:38 PM UTC
Coloplast Q4 EBIT Margin 23%
M impact | EARNINGS | Nov 02, 2026, 05:38 PM UTC
Coloplast Reports Q4 Net Income of DKK 1,186 Million
M impact | EARNINGS | Nov 02, 2026, 05:38 PM UTC